Fibrocor Therapeutics is a Canadian biotech firm focused on developing treatments for kidney diseases, particularly Alport Syndrome, using innovative fibrosis-targeting therapies
Fibrocor Therapeutics is a Canadian biotech firm focused on developing treatments for kidney diseases, particularly Alport Syndrome, using innovative fibrosis-targeting therapies.